ACH
VKTX icon

ArrowMark Colorado Holdings’s Viking Therapeutics VKTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.06M Hold
39,898
0.02% 254
2025
Q1
$964K Hold
39,898
0.02% 252
2024
Q4
$1.61M Sell
39,898
-25
-0.1% -$1.01K 0.02% 242
2024
Q3
$2.53M Hold
39,923
0.03% 220
2024
Q2
$2.12M Sell
39,923
-8
-0% -$424 0.03% 239
2024
Q1
$3.27M Buy
39,931
+24,000
+151% +$1.97M 0.04% 227
2023
Q4
$296K Hold
15,931
﹤0.01% 288
2023
Q3
$176K Hold
15,931
﹤0.01% 298
2023
Q2
$258K Hold
15,931
﹤0.01% 290
2023
Q1
$265K Hold
15,931
﹤0.01% 289
2022
Q4
$150K Hold
15,931
﹤0.01% 295
2022
Q3
$43K Sell
15,931
-1,000
-6% -$2.7K ﹤0.01% 322
2022
Q2
$49K Sell
16,931
-1,150
-6% -$3.33K ﹤0.01% 320
2022
Q1
$54K Sell
18,081
-7,042,722
-100% -$21M ﹤0.01% 339
2021
Q4
$32.5M Sell
7,060,803
-932,408
-12% -$4.29M 0.26% 99
2021
Q3
$50.2M Buy
7,993,211
+322,659
+4% +$2.03M 0.39% 74
2021
Q2
$45.9M Buy
7,670,552
+21,700
+0.3% +$130K 0.35% 82
2021
Q1
$48.4M Sell
7,648,852
-858,938
-10% -$5.43M 0.36% 77
2020
Q4
$47.9M Buy
8,507,790
+519,155
+6% +$2.92M 0.37% 79
2020
Q3
$46.5M Sell
7,988,635
-474,198
-6% -$2.76M 0.44% 66
2020
Q2
$61M Sell
8,462,833
-361,693
-4% -$2.61M 0.63% 55
2020
Q1
$41.3M Buy
8,824,526
+10,948
+0.1% +$51.2K 0.54% 62
2019
Q4
$70.7M Buy
8,813,578
+682,050
+8% +$5.47M 0.63% 56
2019
Q3
$55.9M Buy
8,131,528
+1,280,435
+19% +$8.81M 0.56% 62
2019
Q2
$56.9M Buy
6,851,093
+2,351,889
+52% +$19.5M 0.55% 67
2019
Q1
$44.7M Buy
4,499,204
+701,868
+18% +$6.98M 0.42% 75
2018
Q4
$29.1M Buy
3,797,336
+926,249
+32% +$7.09M 0.31% 96
2018
Q3
$50M Buy
2,871,087
+1,147,105
+67% +$20M 0.42% 81
2018
Q2
$16.4M Buy
1,723,982
+95,231
+6% +$904K 0.15% 129
2018
Q1
$7.12M Buy
+1,628,751
New +$7.12M 0.07% 190